MedTrace Logo

Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia

NCT00557778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2011-04-28

No results posted yet for this study

Summary

Evaluate the benefit (rate of adherence to the treatment), based on the LDL-C reduction in the group that will be exposed to the program of reinforcement of orientation aimed to the patients, compared to the control group, both in previous use of rosuvastatin.

Conditions

  • Patients With Dyslipidemia

Sponsors & Collaborators

Principal Investigators

  • Jose Eduardo Neves, MD · AstraZeneca Brazil Ltda

  • Francisco Jose Saraiva, MD · PUC-Campinas

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00557778 on ClinicalTrials.gov